相关实验视频
Updated: Jan 17, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
23.0K
列沃多巴和深度大脑刺激对帕金森病视力障碍的影响
Sana Aslam1, Markey Olson2, Melissa Kovacs3
1Department of Neurology, Muhammad Ali Parkinson's Center, Barrow Neurological Institute, Phoenix, AZ, USA.
Clinical parkinsonism & related disorders
|September 25, 2025
概括
利沃多巴和深度大脑刺激 (DBS) 在帕金森病 (PD) 患者中没有显著改善视觉症状. 然而,DBS显示了提高阅读速度和对比度灵敏度的趋势,这表明需要进一步调查的潜在好处.
科学领域:
- 神经学 神经学
- 眼科医生 眼科 眼科
- 生物医学工程 生物医学工程
背景情况:
- 帕金森病 (PD) 经常导致视力障碍,影响日常生活.
- 这些缺陷包括视觉空间处理,阅读速度和对比度等问题.
研究的目的:
- 评估勒沃多巴和深度大脑刺激 (DBS) 对PD患者视觉症状的影响.
- 评估阅读速度和颜色对比度灵敏度的变化.
主要方法:
- 在DBS手术前,患者进行视觉评估,并服用药物.
- 测试也发生在DBS编程会话 (脱离药物,有/没有刺激).
- 使用了King-Devick测试和颜色对比视觉测试.
主要成果:
- 乐伏多巴和DBS (开/关) 并没有显著改变阅读速度或对比度.
- 一个不显著的趋势表明,DBS后的快速阅读和黑色色彩对比度灵敏度有所改善.
结论:
- 目前的PD治疗方法 (莱沃多巴,DBS) 在这个小研究中对阅读速度和对比度敏度产生了有限的直接影响.
- 有证据表明,DBS手术可能会带来一些视觉益处,这需要进一步研究.
- 需要创新的策略来增强帕金森病中的视觉功能.
关键词:
敏度 (Acuity) 敏度 (Acuity) 是指敏度 (Acuity) 是指敏度 (Acuity) 是指敏度 (Acuity) 是指敏度 (Acuity) 是指敏度 (Acuity) 是指敏度 (Acuity) 是指敏度 (Acuity) 是指敏度 (Acuity) 是指敏度 (Acuity)深度大脑刺激是什么?利沃多帕 (Levodopa) 是一种可靠的药物.帕金森病是帕金森氏症的一种疾病.阅读 阅读 阅读 阅读视觉 视觉 视觉 视觉 视觉 是一个更多相关视频
相关概念视频
01:24Parkinson's Disease: Treatment
986
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
986
01:15Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K